The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Induction of Heme Oxygenase-1 Expression in Murine Macrophages Is Essential for the Anti-inflammatory Effect of Low Dose 15-Deoxy-Δ12,14-prostaglandin J2
Open accessAbstract
15-Deoxy-Delta 12,14-prostaglandin J2 (15d-PGJ2), a cyclopentenone prostaglandin, displays a potent anti-inflammatory effect at micromolar concentrations (>2 microM) through direct inhibition of nuclear factor (NF)-kappa B activation. Here we show that at submicromolar concentrations (0.1-0.5 microM) 15d-PGJ2 retains the ability to suppress the production of tumor necrosis factor-alpha (TNF-alpha) and nitric oxide (NO) in lipopolysaccharide (LPS)-activated murine J774 macrophages under the conditions of a prolonged incubation (>12 h). Western blot analysis revealed that the expression of the cytoprotective enzyme, heme oxygenase-1 (HO-1), was induced and coincident with the anti-inflammatory action of 15d-PGJ2. Inhibition of HO-1 activity or scavenging carbon monoxide (CO), a byproduct derived from heme degradation, significantly attenuated the suppressive activity of 15d-PGJ2. Furthermore, LPS-induced NF-kappa B activation assessed by the inhibitory protein of NF-kappa B(I kappa B) degradation and p50 nuclear translocation was diminished in cells subjected to prolonged treatment with the low concentration of 15d-PGJ2. Treatment of cells with the protein synthesis inhibitor, cycloheximide, or the specific p38 MAP kinase inhibitor, SB203580, blocked the induction of HO-1 and suppression of LPS-induced I kappa B degradation mediated by 15d-PGJ2. Likewise, HO inhibitor and CO scavenger were effective in abolishing the inhibitory effects of 15d-PGJ2 on NF-kappa B activation induced by LPS. The functional role of CO was further demonstrated by the use of a CO releasing molecule, tricarbonyldichlororuthenium(II) dimer, which significantly suppressed LPS-induced nuclear translocation of p50 as assessed by confocal immunofluorescence. Collectively, these data suggest that even at submicromolar concentrations 15d-PGJ2 can exert an anti-inflammatory effect in macrophages through a mechanism that involves the action of HO/CO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069
Brouard, S., Berberat, P. O., Tobiasch, E., Seldon, M. P., Bach, F. H., & Soares, M. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108317200 · Cited by 306
Research works printed but not linked: 31
- Gilroy, 1999, Nat. Med., 5, 698, 10.1038/9550 · DOI · Paper page
- Forman, 1995, Cell, 83, 803, 10.1016/0092-8674(95)90193-0 · DOI · Paper page
- Kliewer, 1995, Cell, 83, 813, 10.1016/0092-8674(95)90194-9 · DOI · Paper page
- Krey, 1997, Mol. Endocrinol., 11, 779, 10.1210/mend.11.6.0007 · DOI · Paper page
- Jiang, 1998, Nature, 391, 82, 10.1038/34184 · DOI · Paper page
- Li, 2000, Mol. Cell. Biol., 20, 4699, 10.1128/MCB.20.13.4699-4707.2000 · DOI · Paper page
- Straus, 2000, Proc. Natl. Acad. Sci. U. S. A., 97, 4844, 10.1073/pnas.97.9.4844 · DOI · Paper page
- Rossi, 2000, Nature, 403, 103, 10.1038/47520 · DOI · Paper page
- Castrillo, 2000, Mol. Cell. Biol., 20, 1692, 10.1128/MCB.20.5.1692-1698.2000 · DOI · Paper page
- Cernuda-Morollón, 2001, J. Biol. Chem., 276, 35530, 10.1074/jbc.M104518200 · DOI · Paper page
- Maines, 1988, FASEB J., 2, 2557, 10.1096/fasebj.2.10.3290025 · DOI · Paper page
- Abraham, 1996, Cell. Physiol. Biochem., 6, 129, 10.1159/000154819 · DOI · Paper page
- Otterbein, 2000, Am. J. Physiol., 279, L1029
- Colville-Nash, 1998, J. Immunol., 161, 978, 10.4049/jimmunol.161.2.978 · DOI · Paper page
- Kitamura, 1999, Neurosci. Lett., 262, 129, 10.1016/S0304-3940(99)00055-5 · DOI
- Wayman, 2002, FASEB J., 16, 1027, 10.1096/fj.01-0793com · DOI · Paper page
- Straus, 2001, Med. Res. Rev., 21, 185, 10.1002/med.1006 · DOI · Paper page
- Harris, 2002, J. Immunol., 168, 1372, 10.4049/jimmunol.168.3.1372 · DOI
- Zhang, 2001, J. Immunol., 166, 7104, 10.4049/jimmunol.166.12.7104 · DOI
- Bureau, 2002, J. Immunol., 168, 5318, 10.4049/jimmunol.168.10.5318 · DOI
- Wang, 1998, Am. J. Pathol., 152, 711
- Otterbein, 2000, Nat. Med., 6, 422, 10.1038/74680 · DOI · Paper page
- MacMicking, 1997, Annu. Rev. Immunol., 15, 323, 10.1146/annurev.immunol.15.1.323 · DOI · Paper page
- Gilmore, 1999, Oncogene, 18, 6842, 10.1038/sj.onc.1203237 · DOI · Paper page
- Kyriakis, 2001, Physiol. Rev., 81, 807, 10.1152/physrev.2001.81.2.807 · DOI · Paper page
- Motterlini, 2002, Circ. Res., 90, E17, 10.1161/hh0202.104530 · DOI · Paper page
- Lee, 2002, Nat. Med., 8, 240, 10.1038/nm0302-240 · DOI · Paper page
- Scapagnini, 2002, Mol. Pharmacol., 3, 554, 10.1124/mol.61.3.554 · doi:10.1124/mol.61.3.554 · Paper page
- Kawahito, 2000, J. Clin. Invest., 106, 189, 10.1172/JCI9652 · DOI · Paper page
- Diab, 2002, J. Immunol., 168, 2508, 10.4049/jimmunol.168.5.2508 · DOI · Paper page
- Sarady, 2002, Am. J. Respir. Cell Mol. Biol., 27, 739, 10.1165/rcmb.4816 · DOI
Cited by
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,307
Mechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241
“In addition, several molecules produced under physiologic conditions might act in a similar manner, including the anti-inflammatory cytokine interleukin-10 (55), 15-deoxy-12, 14-prostaglandin J2 (56), vascular endothelial growth factor (57, 58), stromal cell-derived factor 1 (59), nitric oxide (NO) (60), and nerve gro…”
BackgroundHeme oxygenase-1: unleashing the protective properties of heme
Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00181-9 · Cited by 1,166
Inflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Heme oxygenase–1, oxidation, inflammation, and atherosclerosis
Araujo, J. A., Zhang, M., & Yin, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00119 · Cited by 443
Metadata
- Authors
- Lee, T.-S., Tsai, H.-L., & Chau, L.-Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 278
- Issue
- 21
- Pages
- 19325-19330
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2014308014
- Cited by
- 211
- References
- 5
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6354 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.